Objectives To explore perinatal outcomes in severe acute respiratory syndrome coronavirus
2 (SARS‐CoV‐2)‐vaccinated pregnant women compared with unvaccinated counterparts …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generated a
worldwide emergency, until the declaration of the pandemic in March 2020. SARS-CoV-2 …

Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy
on neonatal and maternal outcomes informs clinical decision-making. Here we report a …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to significant changes
in life and healthcare all over the world. Pregnant women and their newborns require extra …

Background Coronavirus disease (COVID-19) infection during pregnancy causes adverse
maternal and perinatal outcomes such as preterm birth, low birth weight, severe illness …

Abstract The coronavirus disease 2019 (COVID-19) outbreak which started in December
2019 rapidly developed into a global health concern. Pregnant women are susceptible to …

During the last two and a half years, clinical manifestations, disease severity, and pregnancy
outcomes have differed among pregnant patients with SARS-CoV-2 infection. These …

Angiotensin-converting enzyme 2 (ACE2) is not only the viral receptor for the novel
coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) but is also …

The COVID-19 pandemic has claimed over six million lives and caused significant
morbidities globally. The development and use of COVID-19 vaccines is a key strategy in …

To date, extensive research has been conducted on vaccination against COVID-19 during
pregnancy to verify the safety and efficacy of the vaccines, despite the fact that pregnant …